651 related articles for article (PubMed ID: 27515382)
21. Timosaponin B-II inhibits lipopolysaccharide-induced acute lung toxicity via TLR/NF-κB pathway.
Zhang T; Wang J; Wang S; Ma C
Toxicol Mech Methods; 2015; 25(9):665-71. PubMed ID: 26540118
[TBL] [Abstract][Full Text] [Related]
22. Acute lung injury induced by lipopolysaccharide is inhibited by wogonin in mice via reduction of Akt phosphorylation and RhoA activation.
Yeh YC; Yang CP; Lee SS; Horng CT; Chen HY; Cho TH; Yang ML; Lee CY; Li MC; Kuan YH
J Pharm Pharmacol; 2016 Feb; 68(2):257-63. PubMed ID: 26749510
[TBL] [Abstract][Full Text] [Related]
23. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
[TBL] [Abstract][Full Text] [Related]
24. Administration of a specific inhibitor of neutrophil elastase attenuates pulmonary fibrosis after acute lung injury in mice.
Fujino N; Kubo H; Suzuki T; He M; Suzuki T; Yamada M; Takahashi T; Ota C; Yamaya M
Exp Lung Res; 2012 Feb; 38(1):28-36. PubMed ID: 22148910
[TBL] [Abstract][Full Text] [Related]
25. Fisetin Alleviates Lipopolysaccharide-Induced Acute Lung Injury via TLR4-Mediated NF-κB Signaling Pathway in Rats.
Feng G; Jiang ZY; Sun B; Fu J; Li TZ
Inflammation; 2016 Feb; 39(1):148-157. PubMed ID: 26272311
[TBL] [Abstract][Full Text] [Related]
26. [The effect of recombinant interleukin-10/Fc fusion protein on lipopolysaccharide-induced acute lung injury in mice].
Bi MH; Wang BE; Zheng XX; Li M; Mayer K; Zhang SW
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Aug; 20(8):461-4. PubMed ID: 18687171
[TBL] [Abstract][Full Text] [Related]
27. Magnolol ameliorates lipopolysaccharide-induced acute lung injury in rats through PPAR-γ-dependent inhibition of NF-kB activation.
Lin MH; Chen MC; Chen TH; Chang HY; Chou TC
Int Immunopharmacol; 2015 Sep; 28(1):270-8. PubMed ID: 26072062
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of neutrophil apoptosis via sphingolipid signaling in acute lung injury.
Lin WC; Lin CF; Chen CL; Chen CW; Lin YS
J Pharmacol Exp Ther; 2011 Oct; 339(1):45-53. PubMed ID: 21724966
[TBL] [Abstract][Full Text] [Related]
29. Esculin alleviates LPS-induced acute lung injury via inhibiting neutrophil recruitment and migration.
Ni J; Li G; Dai N; Quan Z; Tong H; Liu Y
Int Immunopharmacol; 2023 Jun; 119():110177. PubMed ID: 37068336
[TBL] [Abstract][Full Text] [Related]
30. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
Jing W; Chunhua M; Shumin W
Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
[TBL] [Abstract][Full Text] [Related]
31. Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.
Qiushi W; Guanghua L; Guangquan X
Eur J Pharmacol; 2015 Mar; 750():32-8. PubMed ID: 25620130
[TBL] [Abstract][Full Text] [Related]
32. Taraxacum officinale protects against lipopolysaccharide-induced acute lung injury in mice.
Liu L; Xiong H; Ping J; Ju Y; Zhang X
J Ethnopharmacol; 2010 Jul; 130(2):392-7. PubMed ID: 20510343
[TBL] [Abstract][Full Text] [Related]
33. Glycyrrhizin treatment is associated with attenuation of lipopolysaccharide-induced acute lung injury by inhibiting cyclooxygenase-2 and inducible nitric oxide synthase expression.
Ni YF; Kuai JK; Lu ZF; Yang GD; Fu HY; Wang J; Tian F; Yan XL; Zhao YC; Wang YJ; Jiang T
J Surg Res; 2011 Jan; 165(1):e29-35. PubMed ID: 21074783
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of rutin on LPS-induced acute lung injury via down-regulation of MIP-2 expression and MMP-9 activation through inhibition of Akt phosphorylation.
Chen WY; Huang YC; Yang ML; Lee CY; Chen CJ; Yeh CH; Pan PH; Horng CT; Kuo WH; Kuan YH
Int Immunopharmacol; 2014 Oct; 22(2):409-13. PubMed ID: 25091621
[TBL] [Abstract][Full Text] [Related]
35. Phospholipase Cε plays a crucial role in neutrophilic inflammation accompanying acute lung injury through augmentation of CXC chemokine production from alveolar epithelial cells.
Umezawa K; Nagano T; Kobayashi K; Dokuni R; Katsurada M; Yamamoto M; Yoshikawa Y; Kataoka T; Nishimura Y
Respir Res; 2019 Jan; 20(1):9. PubMed ID: 30634975
[TBL] [Abstract][Full Text] [Related]
36. Erianin alleviates LPS-induced acute lung injury via antagonizing P-selectin-mediated neutrophil adhesion function.
Ni J; Chen X; Chen N; Yan Y; Wu Y; Li B; Huang H; Tong H; Liu Y; Dai N
J Ethnopharmacol; 2024 Sep; 331():118336. PubMed ID: 38750983
[TBL] [Abstract][Full Text] [Related]
37. Improving effect of Sivelestat on lipopolysaccharide-induced lung injury in rats.
Yuan Q; Jiang YW; Fang QH
APMIS; 2014 Sep; 122(9):810-7. PubMed ID: 24484066
[TBL] [Abstract][Full Text] [Related]
38. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of flavonoids extracted from licorice on lipopolysaccharide-induced acute pulmonary inflammation in mice.
Xie YC; Dong XW; Wu XM; Yan XF; Xie QM
Int Immunopharmacol; 2009 Feb; 9(2):194-200. PubMed ID: 19071231
[TBL] [Abstract][Full Text] [Related]
40. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]